drugset / Trial / NCT00707499

A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158

NCT00707499 ↗

Phase 1 Completed 13 enrolled Lantheus Medical Imaging
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this clinical research study is to learn the safety and biodistribution of BMS747158 in normal, healthy volunteers.

Timeline

Start
2007-09
Primary completion
2008-05
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS747158 Diagnostic / imaging agent — —

Indications

No indication recorded.